• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腓骨肌萎缩症 1A 型患者皮肤有髓神经纤维的节段性缩短。

Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.

机构信息

Department of Neurology, Wayne State University, Detroit 48201, USA.

出版信息

Brain. 2009 Dec;132(Pt 12):3263-73. doi: 10.1093/brain/awp274.

DOI:10.1093/brain/awp274
PMID:19923170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2800385/
Abstract

Charcot-Marie-Tooth disease type 1A is the most common inherited neuropathy and is caused by duplication of chromosome 17p11.2 containing the peripheral myelin protein-22 gene. This disease is characterized by uniform slowing of conduction velocities and secondary axonal loss, which are in contrast with non-uniform slowing of conduction velocities in acquired demyelinating disorders, such as chronic inflammatory demyelinating polyradiculoneuropathy. Mechanisms responsible for the slowed conduction velocities and axonal loss in Charcot-Marie-Tooth disease type 1A are poorly understood, in part because of the difficulty in obtaining nerve samples from patients, due to the invasive nature of nerve biopsies. We have utilized glabrous skin biopsies, a minimally invasive procedure, to evaluate these issues systematically in patients with Charcot-Marie-Tooth disease type 1A (n = 32), chronic inflammatory demyelinating polyradiculoneuropathy (n = 4) and healthy controls (n = 12). Morphology and molecular architecture of dermal myelinated nerve fibres were examined using immunohistochemistry and electron microscopy. Internodal length was uniformly shortened in patients with Charcot-Marie-Tooth disease type 1A, compared with those in normal controls (P < 0.0001). Segmental demyelination was absent in the Charcot-Marie-Tooth disease type 1A group, but identifiable in all patients with chronic inflammatory demyelinating polyradiculoneuropathy. Axonal loss was measurable using the density of Meissner corpuscles and associated with an accumulation of intra-axonal mitochondria. Our study demonstrates that skin biopsy can reveal pathological and molecular architectural changes that distinguish inherited from acquired demyelinating neuropathies. Uniformly shortened internodal length in Charcot-Marie-Tooth disease type 1A suggests a potential developmental defect of internodal lengthening. Intra-axonal accumulation of mitochondria provides new insights into the pathogenesis of axonal degeneration in Charcot-Marie-Tooth disease type 1A.

摘要

腓骨肌萎缩症 1A 型是最常见的遗传性周围神经病,由 17p11.2 染色体重复引起,该区域包含外周髓鞘蛋白 22 基因。这种疾病的特征是传导速度均匀减慢和继发轴突丢失,与获得性脱髓鞘疾病(如慢性炎症性脱髓鞘性多发性神经病)的传导速度不均匀减慢形成对比。腓骨肌萎缩症 1A 型传导速度减慢和轴突丢失的机制尚不清楚,部分原因是由于神经活检的侵袭性,难以从患者身上获得神经样本。我们利用无毛皮肤活检,一种微创程序,在腓骨肌萎缩症 1A 型患者(n=32)、慢性炎症性脱髓鞘性多发性神经病患者(n=4)和健康对照者(n=12)中系统地评估这些问题。使用免疫组织化学和电子显微镜检查皮肤有髓神经纤维的形态和分子结构。与正常对照组相比,腓骨肌萎缩症 1A 型患者的节段性脱髓鞘缺失(P<0.0001),但所有慢性炎症性脱髓鞘性多发性神经病患者均存在节段性脱髓鞘。使用 Meissner 小体的密度可以测量轴突丢失,并与轴内堆积的线粒体相关。我们的研究表明,皮肤活检可以揭示区分遗传性和获得性脱髓鞘神经病的病理和分子结构改变。腓骨肌萎缩症 1A 型的均匀缩短的节间长度表明节间延长的潜在发育缺陷。线粒体在轴内的堆积为腓骨肌萎缩症 1A 型轴突变性的发病机制提供了新的见解。

相似文献

1
Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.腓骨肌萎缩症 1A 型患者皮肤有髓神经纤维的节段性缩短。
Brain. 2009 Dec;132(Pt 12):3263-73. doi: 10.1093/brain/awp274.
2
Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.遗传性脱髓鞘神经病伴外周髓鞘蛋白 22 基因突变。
Brain. 2011 Feb;134(Pt 2):608-17. doi: 10.1093/brain/awq374. Epub 2011 Jan 19.
3
Internodal length variability of dermal myelinated fibres.皮肤有髓神经纤维的结间长度变异性
Brain. 2010 Jun;133(Pt 6):e142; author reply e143. doi: 10.1093/brain/awq004. Epub 2010 Feb 15.
4
Charcot-Marie-Tooth disease: New insights from skin biopsy.夏科-马里-图思病:皮肤活检的新见解
Neurology. 2015 Oct 6;85(14):1202-8. doi: 10.1212/WNL.0000000000001993. Epub 2015 Sep 11.
5
Intraepidermal nerve fibre density as biomarker in Charcot-Marie-Tooth disease type 1A.表皮内神经纤维密度作为1A型遗传性运动感觉神经病的生物标志物。
Brain Commun. 2020 Feb 12;2(1):fcaa012. doi: 10.1093/braincomms/fcaa012. eCollection 2020.
6
Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside.髓鞘相关神经病的皮肤活检:将分子病理学应用于临床
Brain. 2005 May;128(Pt 5):1168-77. doi: 10.1093/brain/awh483. Epub 2005 Mar 17.
7
Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.腓肠神经脱髓鞘在慢性炎症性脱髓鞘性多发性神经病中的诊断价值
Brain. 2001 Dec;124(Pt 12):2427-38. doi: 10.1093/brain/124.12.2427.
8
A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.一种 1A 型腓骨肌萎缩症的大鼠模型再现了疾病的变异性,并为患者的轴突丧失提供了生物标志物。
Brain. 2012 Jan;135(Pt 1):72-87. doi: 10.1093/brain/awr322. Epub 2011 Dec 20.
9
Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.靶向集落刺激因子 1 受体可缓解两种形式的 Charcot-Marie-Tooth 病小鼠模型的症状。
Brain. 2015 Nov;138(Pt 11):3193-205. doi: 10.1093/brain/awv240. Epub 2015 Aug 21.
10
Clinicopathologic analysis of 124 biopsy-proven peripheral nerve diseases.124例经活检证实的周围神经疾病的临床病理分析
J Korean Med Sci. 2000 Apr;15(2):211-6. doi: 10.3346/jkms.2000.15.2.211.

引用本文的文献

1
Basic Pathological Mechanisms in Peripheral Nerve Diseases.周围神经疾病的基本病理机制
Int J Mol Sci. 2025 Apr 4;26(7):3377. doi: 10.3390/ijms26073377.
2
Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases.靶向 PMP22 基因剂量疾病啮齿动物模型中的 PI3K/Akt/mTOR 信号通路。
EMBO Mol Med. 2024 Mar;16(3):616-640. doi: 10.1038/s44321-023-00019-5. Epub 2024 Feb 21.
3
CMT1A current gene therapy approaches and promising biomarkers.CMT1A当前的基因治疗方法及有前景的生物标志物。
Neural Regen Res. 2023 Jul;18(7):1434-1440. doi: 10.4103/1673-5374.361538.
4
Skin Biopsy as a Novel Diagnostic Aid in Immune-Mediated Neuropathies.皮肤活检作为免疫介导性神经病的一种新型诊断辅助手段。
J Neuropathol Exp Neurol. 2022 Nov 16;81(12):1018-1025. doi: 10.1093/jnen/nlac085.
5
Investigation of nerve fibers in the skin by biopsy: technical aspects, indications, and contribution to diagnosis of small-fiber neuropathy.皮肤神经纤维活检:技术要点、适应证及对小纤维神经病诊断的价值。
Einstein (Sao Paulo). 2022 Jul 8;20:eMD8044. doi: 10.31744/einstein_journal/2022MD8044. eCollection 2022.
6
Mechanisms and Treatments in Demyelinating CMT.脱髓鞘 CMT 的发病机制与治疗方法。
Neurotherapeutics. 2021 Oct;18(4):2236-2268. doi: 10.1007/s13311-021-01145-z. Epub 2021 Nov 8.
7
AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A.AAV2/9 介导的 PMP22 沉默可预防 1A 型腓骨肌萎缩症大鼠模型中病理性特征的发展。
Nat Commun. 2021 Apr 21;12(1):2356. doi: 10.1038/s41467-021-22593-3.
8
Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A.鲨烯酰 siRNA PMP22 纳米颗粒可有效治疗 1A 型腓骨肌萎缩症小鼠模型。
Commun Biol. 2021 Mar 9;4(1):317. doi: 10.1038/s42003-021-01839-2.
9
Contribution of Skin Biopsy in Peripheral Neuropathies.皮肤活检在周围神经病变中的作用
Brain Sci. 2020 Dec 15;10(12):989. doi: 10.3390/brainsci10120989.
10
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A.利用鞘脂和甘油磷脂损伤来选择用于CMT1A的有效药物和生物标志物。
Front Neurol. 2020 Aug 25;11:903. doi: 10.3389/fneur.2020.00903. eCollection 2020.

本文引用的文献

1
PMP22 expression in dermal nerve myelin from patients with CMT1A.CMT1A患者真皮神经髓鞘中的PMP22表达。
Brain. 2009 Jul;132(Pt 7):1734-40. doi: 10.1093/brain/awp113. Epub 2009 May 15.
2
Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A.1A型夏科-马里-图斯病患儿的神经生理异常
J Peripher Nerv Syst. 2008 Sep;13(3):236-41. doi: 10.1111/j.1529-8027.2008.00182.x.
3
Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration.FIG4基因的突变会导致快速进展的、不对称的神经元变性。
Brain. 2008 Aug;131(Pt 8):1990-2001. doi: 10.1093/brain/awn114. Epub 2008 Jun 12.
4
Myelinated nerve endings in human skin.人类皮肤中的有髓神经末梢。
Muscle Nerve. 2007 Jun;35(6):767-75. doi: 10.1002/mus.20771.
5
Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes.髓鞘蛋白零基因中R69C突变对髓鞘形成和离子通道亚型的影响。
Arch Neurol. 2006 Dec;63(12):1787-94. doi: 10.1001/archneur.63.12.1787.
6
Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice.外周髓鞘蛋白22缺陷小鼠神经的发育异常
J Neurosci Res. 2007 Feb 1;85(2):238-49. doi: 10.1002/jnr.21118.
7
Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B.皮肤活检显示在遗传性运动感觉神经病1B型中存在髓磷脂蛋白零(MPZ)剪接异常。
Neurology. 2006 Oct 10;67(7):1141-6. doi: 10.1212/01.wnl.0000238499.37764.b1.
8
Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.主要髓磷脂蛋白基因(P0)突变导致一种新型轴突变性。
J Comp Neurol. 2006 Sep 10;498(2):252-65. doi: 10.1002/cne.21051.
9
Morphological features of nerves in skin biopsies.皮肤活检中神经的形态学特征。
J Neurol Sci. 2006 Mar 15;242(1-2):15-21. doi: 10.1016/j.jns.2005.11.010. Epub 2006 Jan 31.
10
Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.外周髓鞘蛋白22与α6β4整合素形成复合物,其缺失会改变施万细胞基膜。
J Neurosci. 2006 Jan 25;26(4):1179-89. doi: 10.1523/JNEUROSCI.2618-05.2006.